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Abstract Background: Glucose
control (GC) with insulin decreases
morbidity and mortality of critically
ill patients. In this study we investi-
gated GC performance over time
during implementation of GC strate-
gies within three intensive care units
(ICUs) and in routine clinical prac-
tice. Methods: All adult critically ill
patients who stayed for[24 h
between 1999 and 2007 were inclu-
ded. Effects of implementing local
GC guidelines and guideline revisions
on effectiveness/efﬁciency-related
indicators, safety-related indicators,
and protocol-related indicators were
measured. Results: Data of 17,111
patient admissions were evaluated,
with 714,141 available blood glucose
levels (BGL) measurements. Mean
BGL, time to reach target, hypergly-
cemia index, sampling frequency,
percentage of hyperglycemia events,
and in-range measurements statisti-
cally changed after introducing GC in
all ICUs. The introduction of simple
rules on GC had the largest effect.
Subsequent changes in the protocol
had a smaller effect than the intro-
duction of the protocol itself. As soon
as the protocol was introduced, in all
ICUs the percentage of hypoglycemia
events increased. Various revisions
were implemented to reduce hypo-
glycemia events, but levels never
returned to those from pre-imple-
mentation. More intensive
implementation strategies including
the use of a decision support system
resulted in better control of the pro-
cess. Conclusion: There are various
strategies to achieve GC in routine
clinical practice but with variable
success. All of them were associated
with an increase in hypoglycemia
events, but GC was never stopped.
Instead, these events have been
accepted and managed. Statistical
process control is a useful tool for
monitoring phenomena over time and
captures within-institution changes.
Keywords Glucose control 
Glucose regulation  Critical care 
Clinical guideline  Statistical process
control  Decision support system
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DOI 10.1007/s00134-010-1924-3 ORIGINALIntroduction
Hyperglycemia is frequently encountered in critically ill
patients [1, 2]. The underlying physiology of hypergly-
cemia that drives mortality, independently of glucose
control (GC), has been described [3, 4]. GC aiming at
normoglycemia [i.e.,blood glucoselevel (BGL)of 80–110
mg/dl, frequently referred to as ‘‘tight glycemic control’’]
decreased morbidity and mortality of critically ill patients
in two randomized controlled trials [5, 6]. Recent pub-
lished meta-analysis [7, 8] could not conﬁrm the beneﬁts
of GC, but there are some important methodological
concerns about this study [9, 10] and many intensive care
units (ICUs) still use GC in their routine clinical practice.
Although some studies showed that the implementation of
GC with insulin came with the risk of hypoglycemia [5, 6,
11–13], others did not [14–18]. Some studies therefore
advise maintaining a BGL\150 mg/dl [19–21]. Another
recent randomized controlled trial showed that maintain-
ing BGL\180 mg/dl is superior to adhering to the tight
glycemic control in terms of mortality and morbidity [22].
However, this result should be interpreted in the context of
the speciﬁc implemented guideline and the level of com-
pliance with it. This context is important because the
quality of GC and outcome are directly linked [1, 23, 24].
Determining how and for whom GC is safe and
effective remains quite elusive [25–27]. Implementing
GC as well as the performance of the GC process itself is
of great importance in intensive care medicine. To mea-
sure GC performance one has to determine and deﬁne
adequate performance indicators and analyze these
indicators over time. This implies monitoring the imple-
mentation process and determining whether GC is truly
applied and functioning at a consistent and acceptable
level. Statistical process control (SPC) is a powerful tool
for quality measurement of phenomena over time and the
improvement of processes [28].
Our objective was to study GC performance over time
during implementation of this strategy in three different
ICUs. First, we described and analyzed the performance
of GC in the early stage of GC but before implementation
of local guidelines, and after the implementation of a
written guideline in each center. Second, we analyzed
differences between simple and complex guidelines, and
between non-computerized and computerized GC. In
addition, we described the inﬂuence of concerns of cli-
nicians and nurses regarding the safety of GC.
Methods
Study locations
Collection of data was performed in three closed-format
mixed medical-surgical ICUs in the Netherlands. ICU-A
is a 30-bed ICU of an academic hospital. ICU-B is a
10-bed ICU of a nonacademic teaching hospital. ICU-C is
an 18-bed ICU of a nonacademic teaching hospital. In
ICU-A and ICU-C, physicians are constantly present.
ICU-A (March 2002) and ICU-C (April 2001) were
equipped with a patient data management system
(PDMS). The PDMS can display and process all BGLs
directly after their measurement with a maximum delay of
1 min.
Local glucose control guidelines
Tables 1 and 2 show the guideline characteristics and
changes in them over time. Note that for severe hypo-
glycemia events, the guidelines recommend stopping
insulin infusion as well as injecting glucose.
Patients
All adult critically ill patients who stayed for [24 h
between 1999 and 2007 were included. The hospital
information system and PDMS were searched for all
records on BGL for these patients. The ﬁrst BGLs directly
after ICU admittance were excluded from the ﬁnal anal-
ysis because we considered them not to be inﬂuenced by
any ICU regimen.
Performance indicators and deﬁnitions
The most common performance indicators [29] were
selected to show the quality of glucose regulation in the
three ICUs. The indicators, described in Table S1 in the
electronic supplementary material (ESM), were catego-
rized in three groups: effectiveness/efﬁciency-related
indicators (mean BGL, BGL within predeﬁned targets,
and time to reach target), safety-related indicators (severe
hypoglycemia, hyperglycemia, and hyperglycemia index),
and protocol-related indicators (sampling frequency).
Statistical analysis
We used the SPC technique, described in the ESM, and
the XMR control chart [30] to construct and analyze the
processes. Due to big subgroup size and the increasing
chance of a false-positive result, we used the XMR chart
in place of attribute charts [31, 32]. The quality indicators
that we chose were calculated per quarter and plotted as
points on the XMR chart. The mean of the points before
GC implementation was calculated along with the ±3
sigma limits. To determine whether a change in the pro-
cess occurs further along the time axis, the mean and
process control limits were extrapolated over the entire
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1558study period. Because the time of intervention is known
and because the process is stable (i.e., not ‘‘out of con-
trol’’ according to the SPC rules) before and after the
intervention, the mean and process control limits were
recalculated in the intervention period. The Kruskal-
Wallis H, Mann-Whitney U, and chi-squared tests were
used to assess the statistical signiﬁcance of differences
among pre- and post-intervention periods and to compare
these results with those of the SPC analysis. All analysis
was performed with Systat 12.
Results
Patients
In total 9,392, 2,968, and 4,751 admissions from ICU-A
and ICU-B (from 1 January 1999 to 31 September 2007)
and ICU-C (from 1 January 2001 to 31 September 2007),
respectively, were extracted and analyzed. Table S2 in the
ESM shows the patient baseline characteristics including
age, gender, APACHE III score, admission type, ICU
mortality, and length of stay in each year of study. SPC
Table 2 Description of guidelines revisions in three studied ICUs
ICU Date of change Description
A Before November 2001 For a long time, hyperglycemia was considered an adaptive response to critical illness. Therefore before
publication of the ﬁrst randomized controlled trial showing beneﬁt of tight glycemic control, only BGL
[200 mg/dl was a reason to start insulin infusion.
November 2001
(major change I)
A simple guideline on glucose control was implemented involving all ICU patients. The BGL target in
this ﬁrst written protocol was 80–144 mg/dl. Glucose control was considered a combined ICU
physician and ICU nurse activity; initiation of insulin infusion was by the attending ICU physician (and
never the ICU nurse), changes in insulin infusion were by ICU physician and/or ICU nurse. The
protocol did not make recommendations on timing of BGL measurements.
August 2004
(major change II)
A more strict guideline was implemented. The recommendations on infusion pump speeds were far more
complex, using sliding scales. This protocol was completely nurse-driven; initiation of and all changes
in insulin infusion were done only by the attending ICU nurse (and never the ICU physician). The new
guideline made recommendations on timing of BGL measurements. In addition, there were now also
recommendations for treatment of hypoglycemia and for the frequency of BGL measurements after
hypoglycemia.
May 2005
(major change III)
The guideline was slightly revised to decrease the risk for severe hypoglycemia. From then on the
guideline recommendations strived for BGL of 90–144 instead of 80–144 mg/dl.
B November 2001
(major change I)
A written guideline on glucose control was introduced. The guideline was similar to the one used in
ICU-A, with the exception that this guideline aimed at BGL of 90–144 instead of 80–144 mg/dl.
September 2004
(major change II)
A more strict glucose control guideline was implemented, aiming at BGL between 80 and 144 mg/dl.
Similar to the ﬁrst version, in this guideline glucose control was also a combined ICU physician and
ICU nurse activity. The new guideline made recommendations on timing of BGL measurements. The
protocol provided recommendations for infusion pump speeds, using sliding scales. In addition, there
were recommendations for treatment of hypoglycemia and for the frequency of BGL measurements
after hypoglycemia.
May 2005
(major change III)
The ICU team concluded that the guideline was too strict and rigid; in particular it was considered to
cause too many hypoglycemic events. It was decided to no longer use the guideline and a simple order
was added to the chart by the attending ICU physician stating that the BGL should be between 80 and
110 mg/dl. It was left to the ICU nurses to decide whether or not to use the previous guideline and to
start and adapt insulin infusion whenever necessary. The same held for the BGL measurements, i.e.,
they were taken whenever ICU nurses considered that to be necessary. Only in case of difﬁculties in
making decisions pertaining to glucose control the attending ICU physician was consulted. Thus from
then on the guideline was considered to be merely ICU nurse based.
C Before November 2001 BGLs were considered acceptable between 180 and 216 mg/dl.
November 2001
(major change I)
It was simply recommended that BGL should be more strictly controlled.
April 2002 A simple written guideline aiming at glucose control with BGL targets of 72–126 mg/dl was introduced.
This guideline was completely nurse-driven.
January 2003
(major change II)
The guideline was evaluated and found insufﬁcient. This led to the development of a new written
guideline, introduced at the bedside. The guideline provided recommendations for infusion pump
speeds, using a diagram. Compared to the 1-page sliding scale used in ICU-A and ICU-B, this
4-page diagram was far more complex. It had many extra steps and more detailed rules, with
recommendations on timing of BGL measurements. There were also recommendations for treatment of
hypoglycemia and for the frequency of BGL measurements after hypoglycemia.
May 2003
(major change III)
This elaborate guideline was transformed into a computerized decision support system (CDSS), a custom-
made Visual Basic application integrated within the PDMS [37]. This CDSS was introduced at 50% of
the beds (as part of a study). The application displayed glucose and insulin data and suggested
adjustments in insulin dose and the interval to the next BGL measurement.
September 2003 The CDSS is used for all ICU patients.
1559showed that they were stable and did not change signiﬁ-
cantly during the study period.
Effectiveness and efﬁciency of glucose control
Figure 1 shows the quality process control charts for the
effectiveness/efﬁciency-related indicators of GC in the
three ICUs. Mean BGL decreased and became ‘‘out of
process control’’ (i.e., a change was detected) after imple-
menting the GC guideline in all three ICUs. The
introduction of simple rules on GC had the largest effect in
ICU-A, since GC became more stable with less variation.
Subsequentchangesintheguidelinesdidnothaveeffectsas
large as the introduction of the guideline itself. Mean BGL
in ICU-B was reduced by the introduction of the guideline
butthemeanBGLstillremainedhigherandlessstablefrom
quarter to quarter than in the other two ICUs. Similar to
ICU-A, in ICU-C the implementation of the GC guideline
had a large effect on BGL, but with the introduction of the
computerized decision support system (CDSS) the mean
BGL decreased further and GC stabilized.
The percentage of BGLs within locally deﬁned targets
increasedafterintroducingGCguidelinesinallthreeICUs.
In ICU-A, the subsequent revisions in the protocol did not
change this percentage. As with mean BGLs, the percent-
age of BGLs within target in ICU-B changed signiﬁcantly
with the two changes in the protocol. In ICU-C, both the
introduction of GC as well as the introduction of the CDSS
increased the percentage of BGLs within targets.
Time to reach targets decreased after introducing the
ﬁrst GC guideline in ICU-A and ICU-C. The means of
this indicator in ICU-A were better than in ICU-C before
introducing the protocol. But in ICU-C after protocol
introduction, and especially with CDSS implementation,
the mean of this indicator rapidly decreased and eventu-
ally it was half of that in ICU-A. After protocol
implementation in ICU-B, the mean time to reach target
ranges decreased stepwise with changes in the protocol,
but was comparable to the other two ICUs with less sta-
bility and higher mean.
Safety of glucose control
Process control charts of safety-related quality indicators
are shown in Figs. 2 and 3. As soon as the guidelines were
introduced, in all three ICUs the percentage of BGL
measurements B40 mg/dl increased. In ICU-A, the ﬁrst
revision of the guideline decreased both severe and non-
severe hypoglycemia events. In ICU-B, with all changes
in the protocol, the incidence of hypoglycemia increased.
In ICU-C, these indicators increased after introducing GC
and further increased after CDSS implementation. Com-
pared to the other two ICUs, the percentage of BGL
measurements B40 mg/dl in ICU-B was less stable with
more variation from quarter to quarter before the third
revision in the GC guideline.
Protocol-related indicator
Mean interval between BGL measurements decreased
after introducing the GC guidelines in ICU-A and ICU-C
(Fig. 4). In ICU-A this interval was smaller than in ICU-C
before introducing the protocol. But after introduction of
the guideline in ICU-C, especially with the CDSS
implementation, this mean rapidly decreased and was
even half of that in ICU-A. With the introduction and
subsequent changes of the guideline in ICU-B, the mean
interval between BGL measurements decreased, but
compared to the other two ICUs, with less stability and
with higher means especially before the third revision.
Both reductions were statistically signiﬁcant.
The results of nonparametric and chi-squared tests on
the effect of introducing GC and related changes on these
indicators were concordant with the SPC results (data not
shown).
We used all data from 31 September 2005 till 31
September 2007 because all ICUs declared there were no
other interventions that could have affected GC in this
period. The SPC charts also showed the processes were
stable for all indicators in all three ICUs in this period.
Median BGL in ICU-C and ICU-B was signiﬁcantly
lower than ICU-A. The percentage of patients with at
least one hypoglycemia event and overall percentage of
hypoglycemia and severe hypoglycemia events were
signiﬁcantly higher in ICU-C and ICU-B. Other statisti-
cally (and seemingly clinically) signiﬁcant differences
were in BGL measurement interval, and time to reach
target, which were lower in ICU-C (Table S3 in the
ESM).
Discussion
The effect of introducing GC guidelines and the various
implementations on the quality of GC, especially for an
extended period of time, is unknown. The implementation
strategies of GC ranged from raising awareness to
employing a computerized decision support system. In all
three ICUs, regardless of strategy, there was a continuous
and signiﬁcant improvement in the effectiveness and
efﬁciency indicators, an increase in hypoglycemic-related
indicators, and an increase in BGL measurements. How-
ever, the speed of change and the ﬁnal outcomes differed
signiﬁcantly among the three ICUs.
With SPC, data are plotted and interpreted in a time
series rather than merely comparing before and after
measures. With this method special causes of variation
were easily distinguished from common causes. Process
1560control charts showed which parts of the processes were
more stable and also showed the duration of change after
each intervention. SPC charts in Figs. 1, 2, 3 and 4
showed the diversity in results for implementing similar
protocols in three different centers and reﬂected a range
of ‘‘error’’, all else being equal, in implementing a pro-
tocol with differing interpretations and implementation
details. Those wishing to use SPC as a tool for
Fig. 1 Control charts of mean BGL, time to reach target range,
percentage of BGLs in range predeﬁned in the protocols, and
percentage of BGLs between 63 and 150 mg/dl (efﬁciency-related
indicators). An asterisk means that the indicator was not only
inﬂuenced by performance but also by deﬁnition of targets, and that
because of the latter sharp changes over time could be recognized.
When the data points are, without any special-cause variation,
within the process control limits then the process is said to be ‘‘in
control’’ and stable. Common rules for distinguishing a special-
cause variation (i.e., a structural change): one or more points above
or below the process control limit, a run of eight (or seven) or more
points on one side of the center line, two out of three consecutive
points appearing beyond 2 sigmas on the same side of the center
line, a run of eight (or seven) or more points all trending up or down.
Because the time of intervention (major changes) is known and
because the process was stable (i.e., not ‘‘out of control’’ according
to the SPC rules) before and after the intervention, the mean and
process control limits are recalculated in the intervention period
1561longitudinal self-examination of performance are referred
to [31].
This study has three main strengths. First, to our
knowledge this is the ﬁrst report on effects of GC in
routine daily clinical practice over an extended period of
time. Second, to visualize and make inferences on the
longitudinal development of quality indicators, we used
the powerful instrument of process control charts from the
ﬁeld of SPC. Third, we studied three different ICUs
employing different GC strategies. There are however
Fig. 2 Control charts of percentage of patients with at least one BGL B 40 mg/dl and percentage of BGL B40 mg/dl (safety-related
indicators)
Fig. 3 Control charts of mean hyperglycemia index and percentage of BGL[150 mg/dl (safety-related indicators)
1562also limitations to our study. First, we did not perform
subgroup analysis (such as surgical vs. medical patients).
Second, we did not investigate the inﬂuence of GC on
clinically relevant endpoints such as survival. However,
as GC has been shown to be an evidence-based strategy
that decreases morbidity and mortality [5, 6], adherence
to this strategy is commonly advocated. Third, the actual
adherence to the protocols is unknown. However, the fact
that the quality indicators were signiﬁcantly inﬂuenced
implies that the protocols are being increasingly followed.
Finally, because nutrition data were not available for the
whole study period, we could not investigate the possible
effect of nutrition on the quality of GC. However, nutri-
tion input is not likely to have changed over the study
period within each hospital. In addition, the protocol
should be robust to reasonable ﬂuctuations in the given
nutritional carbohydrate levels.
Usually routine clinical practice characteristics and
limitations are not considered in randomized control trial
(RCTs) and guidelines. This is one explanation for the
underuse of treatments in routine practice that were
beneﬁcial in trials and that are recommended in guide-
lines. Among tight glycemic control (TGC) studies, some
have explicitly considered routine practice issues in their
design, e.g., [14, 15, 17]. However, we in addition mon-
itored performance during actual use of the protocol over
time with SPC.
Relaxing the GC range to a wider, locally workable
target can perhaps be explained by an associated ‘‘fear’’
of hypoglycemia. Brunkhorst et al. showed that the rate of
patients with at least one episode of severe hypoglycemia
(B40 mg/dl) was higher in the study group than in the
control group (17.0 vs. 4.1%, P\0.001) [11]. Although
they reported that no serious adverse events were found,
the trial was nonetheless stopped due to the hypoglycemic
episodes. Interestingly our results showed that in routine
practice, and in contrast to the clinical trials, GC was not
stopped although the rate of patients with at least one
hypoglycemia event were relatively high even with less
tight target ranges (9% in the ICU-B and ICU-C after
the last guideline revision). Although concern about
increasing the percentage of hypoglycemic patients
resulted in terminating the use of the more detailed pro-
tocol in ICU-B, thereafter an even tighter target range was
used in this ICU, and the percentage of hypoglycemic
patients increased even after these revisions. Protocol
failure and/or lack of compliance could partly explain this
result, but we do not have data to test these hypotheses.
Vriesendorp et al. and Chase et al. showed that TGC-
induced hypoglycemia was not associated with worse
outcome [17, 33], although recent studies have reported
such an association [22, 34]. Association of hypoglycemia
with worse outcome may be related to the protocols in
use. Fear of hypoglycemia and its reputation as being
more dangerous than hyperglycemia in the critically ill
may well be based on deeply rooted emotional beliefs
rather than on evidence [35]. Our study demonstrates that
as long as continuous measurement tools are not avail-
able, hypoglycemia events are considered acceptable and
can be consequently managed.
Our results also showed that any decrease in mean
BGL resulted in an increase in the percentage of hypo-
glycemia events. ICU-C, which eventually had the lowest
mean BGL, also had the highest percentage of hypogly-
cemia events. The complex guidelines and the use of the
CDSS, resulting in a mean measurement interval in ICU-
C of 120 min, may have led to more early (and possibly
more frequent) detection of the hypoglycemia. Also
minimum BGL in ICU-A and ICU-B was associated with
maximum percentage of hypoglycemia events. Revising
the protocol in ICU-A decreased the hypoglycemia events
but could not return the level to what it was before
implementing GC.
Shortly after the ﬁrst presentation on TGC in
November 2001 [6], there were either no written guide-
lines in the participating ICUs or the guidelines were very
simple and in a development phase. SPC charts showed
that awareness of TGC, regardless of the guidelines in
place, brought about the maximum changes in the related
indicators. However, thereafter there remained little room
for improvement. After this stage, stronger interventions,
such as more complex protocols and the use of a CDSS,
Fig. 4 Control chart of mean BGL sampling intervals (protocol-related indicator)
1563were called upon to bring about change, but the level of
change was smaller.
Different strategies were developed to achieve GC in
the three ICUs studied. All have managed to reach an
acceptable control but with different speeds of change and
different variability over time. Both ICUs with detailed
written protocols (ICU-A and ICU-C) had better results
and more stable processes with lower variability from
quarter to quarter than ICU-B. Using a detailed written
protocol with clearly deﬁned steps compared to simple
rules (ICU-B) seems to help the nurses to make better
decisions to control blood glucose.
Our results show that a complex protocol with more
steps and detail in ICU-C had improved effects but only
after including the CDSS as an intervention. In ICU-C the
mean BGL measurement interval also became smaller
than in ICU-A after the CDSS. We can conclude that the
CDSS inﬂuenced the nurses’ behavior by reminding them
about the time of the next BGL test. Probably the shorter
time between measurements is based on differences
between protocols, not the effect of CDSS. However it is
unclear whether the beneﬁcial effects of the CDSS are
mainly due to the more frequent measurements or due to
the complex protocol rules. With the current data we
cannot answer this question. In addition, to achieve such a
low mean BGL, higher costs (CDSS and more nursing and
laboratory utilization) were incurred and patients experi-
enced more hypoglycemia events. Cost-beneﬁt analysis
merits more research when aiming at lower mean BGL.
Frequent BGL measurement is a key element in TGC,
in order to steer the process in a timely manner [14, 17,
36]. In the three studied ICUs, better results were asso-
ciated with more frequent measurements. In ICU-A, there
were many BGL measurements before introducing GC,
since BGL measurements were included with blood gas
analysis, even when there was no intention to measure it.
This might explain some of the fast improvement in
glucose regulation in ICU-A after introducing the guide-
line and the very small variation in sample interval.
Conclusions
There are different successful strategies to realize GC in
routine clinical practice but they have various speeds and
implementations. All of the strategies studied here were
associated with an increase in hypoglycemia events. More
intensive implementation strategies resulted in better
control of the process but at the cost of more ICU
resources, including the use of a decision support system.
SPC is a useful tool for monitoring phenomena over time
and allows for capturing within-institution changes.
Within quality measurement and/or improvement efforts,
SPC can show where the special variations are and where
opportunities lie for improving (adherence to) protocols.
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